Chonnam Med J.  2007 Aug;43(2):67-72.

Mesenchymal Stem Cells and Their Potential as Therapeutics in Ischemic Heart Disease

Affiliations
  • 1The Heart Center of Chonnam National University Hospital, Korea. cecilyk@hanmail.net
  • 2Cardiovascular Research Institute of Chonnam National University, Korea.
  • 3Clinical Trial Center of Chonnam National University Hospital, Korea.

Abstract

There has been a rapid progress in research to reveal the molecular mechanism underlying therapeutic effect of mesenchymal stem cells (MSCs) on cardiovascular diseases. To maximize the beneficial potency of MSCs, various factors such as growth factors and cytokines are applied both directly and indirectly. In addition to modification of stem cell itself, safe and feasible stem cell sources including umbilical cord blood and adipose tissue are actively developed. In conclusion, modified MSCs from various adult tissue were showed beneficial and therapeutic effects on cardiovascular diseases.

Keyword

Mesenchymal stem cell; Myocardial infarction; Modification

MeSH Terms

Adipose Tissue
Adult
Cardiovascular Diseases
Cytokines
Fetal Blood
Humans
Intercellular Signaling Peptides and Proteins
Mesenchymal Stromal Cells*
Myocardial Infarction
Myocardial Ischemia*
Stem Cells
Cytokines
Intercellular Signaling Peptides and Proteins
Full Text Links
  • CMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr